|
|
Volumn 2, Issue 5, 2000, Pages 417-422
|
|
New treatment approaches for metastatic renal cell carcinoma.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
ANTINEOPLASTIC AGENT;
CANCER VACCINE;
INTERLEUKIN 2;
MONOCLONAL ANTIBODY;
ADJUVANT CHEMOTHERAPY;
BONE MARROW TRANSPLANTATION;
CLINICAL TRIAL;
DISEASE FREE SURVIVAL;
HUMAN;
IMMUNOLOGY;
KIDNEY CARCINOMA;
KIDNEY TUMOR;
PATHOLOGY;
PROGNOSIS;
REVIEW;
T LYMPHOCYTE;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE MARROW TRANSPLANTATION;
CANCER VACCINES;
CARCINOMA, RENAL CELL;
CHEMOTHERAPY, ADJUVANT;
CLINICAL TRIALS;
DISEASE-FREE SURVIVAL;
HUMANS;
INTERFERON-ALPHA;
INTERLEUKIN-2;
KIDNEY NEOPLASMS;
PROGNOSIS;
T-LYMPHOCYTES;
|
|
EID: 0034277709
PISSN: 15233790
EISSN: None
Source Type: Journal
DOI: 10.1007/s11912-000-0061-5 Document Type: Review |
|
Times cited : (4)
|
|
References (32)
|
